I’m so used to hearing bullish projections on digital health, it’s refreshing when someone contradicts that assessment. Maybe contradict is the wrong word. But Thomas Rodgers, who joined McKesson Ventures last month after a couple of years with Cambia Health Solutions, thinks it will take a lot longer for the technology to enjoy mainstream adoption. […]
In a panel discussion geared to leaders of early stage companies, a mix of angel and venture investors offered some insights to give entrepreneurs some food for thought in different stages of their dealings with investors. The conversation at the IMPACT 2014 conference in Philadelphia this week included Ellen Weber of Robin Hood Ventures who […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Many life sciences companies want to tap into the anti-aging industry with the hope of producing the next Botox. NAYAderm, a biotechnology company, brought its pitch to the IMPACT conference in Philadelphia this week. It licensed a biologic previously used for wound healing from a Japanese manufacturer. It also signed an agreement with the same company […]